ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 60 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $499,000 | +4.8% | 451,000 | -3.4% | 0.07% | 0.0% |
| Q1 2020 | $476,000 | +126.7% | 467,000 | +155.2% | 0.07% | +163.0% |
| Q4 2019 | $210,000 | -96.2% | 183,000 | -96.2% | 0.03% | -95.7% |
| Q3 2019 | $5,514,000 | -6.8% | 4,780,000 | -3.8% | 0.63% | -6.0% |
| Q2 2019 | $5,919,000 | -40.8% | 4,971,000 | -32.6% | 0.67% | -47.8% |
| Q1 2019 | $9,994,000 | +18.8% | 7,379,000 | -5.7% | 1.28% | +4.5% |
| Q4 2018 | $8,411,000 | +13.5% | 7,823,000 | +11.1% | 1.23% | +37.0% |
| Q3 2018 | $7,410,000 | -18.3% | 7,040,000 | -23.5% | 0.90% | -18.0% |
| Q2 2018 | $9,066,000 | +205.1% | 9,204,000 | +206.8% | 1.10% | +244.3% |
| Q1 2018 | $2,971,000 | – | 3,000,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 9,821,000 | $11,314,000 | 1.07% |
| TFG Asset Management GP Ltd | 6,000,000 | $6,883,000 | 1.02% |
| Alken Asset Management Ltd | 400,000 | $461,000 | 0.79% |
| Lombard Odier Asset Management (Europe) Ltd | 6,525,000 | $7,470,000 | 0.54% |
| CSS LLC/IL | 8,000,000 | $9,158,000 | 0.51% |
| IRON Financial LLC | 505,000 | $578,000 | 0.28% |
| MACKAY SHIELDS LLC | 32,796,000 | $37,597,000 | 0.26% |
| OSTRUM ASSET MANAGEMENT | 400 | $459,000 | 0.22% |
| RWC Asset Management LLP | 4,400,000 | $5,037,000 | 0.20% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,871,000 | $5,580,000 | 0.16% |